Please wait
0001070494EX-FILING FEES 0001070494 2024-09-23 2024-09-23 0001070494 1 2024-09-23 2024-09-23 iso4217:USD xbrli:pure xbrli:shares
Exhibit 107
Calculation of Filing Fee Tables
S-8
Acadia Pharmaceuticals Inc.
Table 1: Newly Registered and Carry Forward Securities
 
                           
        
Security
Type
 
Security
Class
Title
  Fee
Calculation 
or Carry
Forward
Rule
 
Amount
Registered
  Proposed 
Maximum 
Offering 
Price Per 
Unit 
 
Maximum
Aggregate
Offering Price
 
Fee
Rate
  Amount of 
Registration 
Fee
  Carry
 Forward 
Form
Type
  Carry
 Forward 
File
Number
  Carry
Forward
Initial
 Effective 
Date
  Filing Fee
Previously
Paid in
 Connection 
with Unsold
Securities to
be Carried
Forward
 
Newly Registered Securities
                           
Fees to be Paid   1   Equity   Common stock, par value $0.0001 per share   Other   2,400,000   $16.41   $39,384,000.00   $0.0001476   $5,813.08          
                           
Fees Previously Paid                            
 
Carry Forward Securities
                           
Carry Forward Securities                            
                       
Total Offering Amounts:            $39,384,000.00     $5,813.08          
                       
Total Fees Previously Paid:                $0.00          
                       
Total Fee Offsets:                $0.00          
                       
Net Fee Due:                            $5,813.08                
Offering Note
 
1
Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement also registers any additional shares of the Registrant’s common stock, par value $0.0001 per share (the “Common Stock”), that may become issuable under the Registrant’s 2024 Inducement Plan (the “Inducement Plan”) as a result of any stock split, stock dividend, recapitalization or similar event.
Estimated in accordance with Rule 457(c) and Rule 457(h) of the Securities Act solely for purposes of calculating the registration fee, on the basis of the average of the high ($16.73) and low ($16.08) sale price of the Common Stock as reported on The Nasdaq Global Select Market on September 18, 2024, which date is within five business days prior to the filing of this Registration Statement.
Represents 2,400,000 shares of the Common Stock reserved for issuance under the Inducement Plan.